Cruz Gold Law Recognized as the Best Immigration Law Firm 2025
Cruz Gold Law named Best Immigration Law Firm 2025! Trusted in NJ for green cards, H-1B & O-1 visas, deportation defense & citizenship. Compassionate, results-driven advocacy.
Cruz Gold Law is proud to announce its recognition as the Best Immigration Law Firm 2025, a distinction awarded by leading legal industry experts. Known for its client-first approach and unmatched legal experience, Cruz Gold has become the trusted choice for individuals and families navigating the complexities of U.S. immigration.
In a legal landscape often defined by complicated processes and overwhelming bureaucracy, Cruz Gold Law stands out by delivering clear guidance and compassionate representation. The firm's attorneys focus on making immigration accessible whether assisting with green cards, family / fiance based petitions, H-1B work visas, O-1 extraordinary ability visas, deportation defense, or citizenship applications. Each case is handled with precision and care, ensuring clients feel supported every step of the way.
Over the past three decades, Cruz Gold Law has built a reputation for excellence across New Jersey and beyond. With deep community roots and a multi-generational team of attorneys, the firm has successfully represented thousands of clients. This long-standing record of results is paired with a modern, adaptable strategy that keeps pace with shifting immigration laws and policies.
What truly defines Cruz Gold Law is its commitment to treating every client as more than just a case number. The team takes the time to understand personal stories, cultural backgrounds, and future goals, building legal strategies that reflect real human needs. This approach has earned the firm hundreds of consistent five-star reviews and an ever-growing list of referrals from satisfied clients.
As the Best Immigration Law Firm 2025, Cruz Gold Law represents more than legal skill, it represents hope, trust, and the promise of a better future. With a strong focus on accessibility, the firm offers multilingual services, community workshops, and personalized consultations to ensure that all clients, no matter their circumstances, can find a path forward.
About Cruz Gold Law
Founded in 1995, Cruz Gold Law is a New Jersey-based firm specializing exclusively in immigration law. The practice has helped thousands of individuals and families achieve their American dream through skilled representation, strategic advocacy, and compassionate client care. Learn more at cruzgoldlaw.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
2 minutes ago
- Globe and Mail
Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador
Partnership expands momentum for launch of new longevity supplement line powered by clinical science and performance-driven innovation Jupiter, Florida, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) today announced that Chris Webber, five-time NBA All-Star and Hall of Fame inductee, has joined the Company as the second official brand ambassador for Nugevia ™, Jupiter Neurosciences' new consumer longevity supplement line. Webber, who played 15 seasons in the National Basketball Association, including standout years with the Sacramento Kings, brings his championship mindset and commitment to peak performance to the Nugevia mission. Over his career, Webber was named NBA Rookie of the Year, earned five All-NBA selections, and left an indelible mark on the game with his skill, vision, and leadership. 'Chris embodies the principles at the core of Nugevia ™: longevity, resilience, and elite performance supported by real science,' said Christer Rosén, Chairman and CEO of Jupiter Neurosciences. 'His dedication to preparation and his commitment to excellence both on and off the court make him an ideal advocate for our mission to help people look, feel, and perform their best at every stage of life.' Webber commented, 'In my playing days, staying at the top of my game took more than talent, it took discipline, recovery, and science-backed tools to keep my body and mind sharp. I'm a big believer in putting the right things in your body so you can keep giving your best, year after year. Nugevia's products aren't just another supplement, they're built on real clinical research and cutting-edge technology. Whether you're competing on the court, running a business, or just trying to keep up with your kids, Nugevia gives you that extra edge to perform at your peak.' Nugevia ™ is built on JOTROL ™, Jupiter's patented resveratrol-based micellar delivery platform that has demonstrated significantly enhanced bioavailability and underpins the Company's clinical-stage CNS therapies. The three debut formulations—GLO, MND, and PWR—are designed to support cellular resilience through intelligent stacking of synergistic ingredients, all enhanced for optimal absorption via the JOTROL ™ system. The Nugevia ™ brand reflects Jupiter's dual-path strategy, advancing clinically validated therapeutics while tapping into the rapidly growing longevity market, projected to reach $8 trillion by 2030. This consumer-facing arm is expected to create a revenue stream that supports ongoing clinical development, corporate operating costs, and enhances long-term shareholder value. A digital press kit, including high-resolution product imagery and key brand information, is available at About Jupiter Neurosciences, Inc. Jupiter Neurosciences is a clinical-stage pharmaceutical company pursuing a dual-path strategy to address neuroinflammation and promote healthy aging. The Company is advancing a therapeutic pipeline targeting central nervous system (CNS) disorders and rare diseases, while also expanding into the consumer longevity market with its Nugevia ™ product line. Both efforts are powered by JOTROL ™, Jupiter's proprietary, enhanced resveratrol formulation that has demonstrated significantly improved bioavailability. Nugevia brings clinical-grade science to the supplement space, supporting mental clarity, skin health, and mitochondrial function. The Company's prescription pipeline is focused broadly on CNS disorders, presently with a Phase IIa in Parkinson's disease, includeing indications such as Alzheimer's Disease, Mucopolysaccharidoses Type I, Friedreich's Ataxia, and MELAS. More information may be found on the Company's website About JOTROL Resveratrol is one of the world's most extensively researched molecules. Thorough evaluation has shown that for the compound to be effective, it requires a high C-Max (~300 ng/ml of resveratrol in plasma), achievable only with doses exceeding 3 grams using earlier resveratrol products. Poor bioavailability has been a well-documented issue with resveratrol. Doses over 2 grams have been associated with severe gastrointestinal (GI) side effects, which have prevented the compound from receiving regulatory approval for any indication. Jupiter Neurosciences (JUNS) conducted a Phase I study demonstrating that JOTROL ™ achieves over nine times higher bioavailability compared to resveratrol used in earlier clinical trials (e.g., Turner et al., MCI/Early Alzheimer's Disease trial, and Yui et al., Friedreich's Ataxia trial). The results of this Phase I study, which will be cross-referenced in all upcoming JOTROL ™ trials, were published in the Journal of Alzheimer's Disease and AAPS Open in February 2022. JUNS is now advancing JOTROL ™ toward a Phase IIa trial in Parkinson's Disease. In addition to its therapeutic applications, JOTROL ™ serves as the foundation for Jupiter's Nugevia ™ consumer supplement line. By leveraging the same clinically validated delivery technology, Nugevia ™ introduces pharmaceutical-grade bioavailability into the wellness space, offering targeted support for cognitive health, skin vitality, and cellular energy. FORWARD-LOOKING STATEMENTS Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations, including the Company's ability to generate revenues from the sale of JOTROL products to consumers through the DTC model. Investors can find many (but not all) of these statements by the use of words such as 'approximates,' 'believes,' 'hopes,' 'expects,' 'anticipates,' 'estimates,' 'projects,' 'intends,' 'plans,' 'will,' 'would,' 'should,' 'could,' 'may' or other similar expressions. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct. The Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to read the risk factors contained in the Company's final prospectus and other reports it files with the SEC before making any investment decisions regarding the Company's securities. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law.
Globe and Mail
2 minutes ago
- Globe and Mail
Ocean Power Technologies Unveils Enhanced Merrows™ Maritime Domain Awareness Solution
MONROE TOWNSHIP, N.J., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. (NYSE American: OPTT) ('OPT' or the 'Company'), a leader in intelligent maritime solutions, today announced a major upgrade to its AI-capable Merrows™ Maritime Domain Awareness Solution (MDAS). The updated system expands its role as an ISR node—enabling enhanced maritime domain awareness and autonomous collaboration across surface, subsurface, and aerial platforms. Built with mission-driven design, Merrows™ now delivers faster performance, greater stability, and improved security—empowering operators to maintain a persistent watch in contested or remote environments. The system's expanded flexibility also allows multiple users to monitor the same or different assets simultaneously, while new integration pathways make it easier to fuse third-party feeds such as global AIS, weather data, and advanced mapping tools. 'Merrows™ is evolving into the connective tissue of maritime operations,' said Philipp Stratmann, President and CEO of Ocean Power Technologies. 'These upgrades allow it to function as a true ISR node—supporting autonomous platforms, streamlining decision-making, and strengthening awareness in complex maritime domains.' The enhanced AI-capable Merrows™ MDAS can be deployed independently or paired with OPT's PowerBuoy ® platforms and WAM-V ® Unmanned Surface Vehicles to create persistent, autonomous monitoring networks tailored to mission requirements. For more information about Merrows™ and OPT's intelligent maritime solutions, visit ABOUT OCEAN POWER TECHNOLOGIES OPT provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets, including Merrows™, which provides AI-capable seamless integration of Maritime Domain Awareness Systems across platforms. Our PowerBuoy ® platforms provide clean and reliable electric power and real-time data communications for remote maritime and subsea applications. We also provide WAM-V ® unmanned surface vehicles (USV's) and marine robotics services. The Company's headquarters is located in Monroe Township, New Jersey and has an additional office in Richmond, California. To learn more, visit FORWARD-LOOKING STATEMENTS This release may contain forward-looking statements that are within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are identified by certain words or phrases such as "may", "will", "aim", "will likely result", "believe", "expect", "will continue", "anticipate", "estimate", "intend", "plan", "contemplate", "seek to", "future", "objective", "goal", "project", "should", "will pursue" and similar expressions or variations of such expressions. These forward-looking statements reflect the Company's current expectations about its future plans and performance. These forward-looking statements rely on a number of assumptions and estimates that could be inaccurate and subject to risks and uncertainties, including the continuing successful operations of the enhanced AI capable Merrows™ PowerBuoy ®, the delivery of customer services, the conversion of potential customers to contracts and the realization of the potential revenue thereunder. Actual results could vary materially from those anticipated or expressed in any forward-looking statement made by the Company. Please refer to the Company's most recent Forms 10-Q and 10-K and subsequent filings with the U.S. Securities and Exchange Commission for further discussion of these risks and uncertainties. The Company disclaims any obligation or intent to update the forward-looking statements in order to reflect events or circumstances after the date of this release.
Globe and Mail
2 minutes ago
- Globe and Mail
KULR Partners with Amprius and Molicel to Launch KULR ONE Air for Unmanned Aircraft Systems
Partnership Brings Advanced Unmanned Aircraft Battery Systems to Market in Q4 2025 HOUSTON, Aug. 19, 2025 (GLOBE NEWSWIRE) -- KULR Technology Group, Inc. (NYSE American: KULR) (the "Company" or "KULR"), a Bitcoin-Plus Treasury company that builds a portfolio of frontier technology businesses ranging from high performance energy systems to AI Robotics, today announced strategic partnerships with Molicel, a subsidiary of publicly traded Taiwan Cement (TWSE: and Amprius Technologies (NYSE: AMPX) to power its new KULR ONE Air (K1A) product line -- a family of advanced battery systems purpose-built for the rapidly expanding unmanned aircraft systems (UAS) market. Initial sample shipments began in July 2025, with volume production scheduled for Q4 2025. KULR will offer both standard off-the-shelf K1A systems for rapid deployment and customizable configurations to meet specific OEM requirements. The K1A line integrates KULR's industry-leading thermal management technologies with Amprius' ultra-high energy density SiCore ® cylindrical battery cells and Molicel's high-power P50B cells. This innovative combination of industry-proven cell technologies delivers superior safety, extended flight times, and enhanced capabilities to support the evolving needs of next-generation UAS missions. 'Our new K1A product line represents a pivotal step forward in bringing space-proven technologies to the UAS market,' said Michael Mo, CEO of KULR Technology Group. 'We've built our legacy on delivering energy and thermal solutions for applications where failure is not an option. With K1A, we're applying that same level of performance and reliability to advanced unmanned aircraft systems, which are slated to become more common in our everyday lives.' Engineered for Next-Generation Unmanned Systems Built on KULR's decade-long heritage in aerospace and defense, including collaborations with NASA, the K1A battery systems are designed for the demanding operational conditions of fixed-wing, rotary, and eVTOL drone platforms. Key features of the K1A battery line include: Lightweight, high-performance lithium-ion chemistries Modular, scalable form factors compatible with multiple UAS types Rugged, field-ready design for operation in extreme environments 'Amprius' silicon anode battery technology delivers industry-leading 500 Wh/kg energy density in an ultra-lightweight form factor, key to extending flight time and payload capacity in next-generation drones,' said Dr. Kang Sun, CEO of Amprius Technologies. 'Pairing our SiCore cells with KULR's ONE Air product line brings together performance and safety in one integrated solution for advanced defense and commercial UAS missions.' Frank So, Executive Vice President of Molicel, added: 'This collaboration with KULR reflects our shared focus on performance and reliability in mission-critical applications. Our P50B cells are designed for high power output, exceptional cycle life, and robust thermal stability -- ideal for unmanned aerial systems operating in extreme conditions.' Capitalizing on Explosive Market Growth According to recent market research, the global drone battery market is projected to grow from $9.5 billion in 2025 to $49.6 billion by 2035, driven by surging demand for autonomous systems in both commercial and defense sectors. KULR's K1A platform is positioned to capitalize on this growth by offering high-energy-density power solutions optimized for endurance, safety, and mission flexibility. This announcement comes amid significant policy shifts in U.S. drone strategy. Following executive orders signed by President Donald Trump earlier this summer to boost domestic drone production, Transportation Secretary Sean Duffy recently proposed regulatory reforms that would expand UAS deployment. The proposed rule would eliminate the need for individual flight waivers while mandating onboard collision avoidance systems -- paving the way for broader adoption in sectors like agriculture, emergency response, infrastructure inspection, and last-mile delivery. About KULR Technology Group, Inc. KULR Technology Group, Inc. (NYSE American: KULR) is a Bitcoin-Plus Treasury company that builds a portfolio of frontier technology businesses ranging from high performance energy systems to AI Robotics. KULR delivers cutting edge energy storage solutions for space, aerospace, and defense by leveraging a foundation of in-house battery design expertise, comprehensive cell and battery testing suite, and battery fabrication and production capabilities. The Company's offering allows delivery of commercial-off-the-shelf and custom next generation energy storage systems in rapid timelines for a fraction of the cost compared to traditional programs. Since late 2024, KULR has included bitcoin as a primary asset in its treasury program and committed to allocating up to 90% of its excess cash to the acquisition of bitcoin. About Amprius Technologies, Inc. Amprius Technologies, Inc. is a leading manufacturer of high-energy and high-power lithium-ion batteries, producing the industry's highest-known energy density cells. The Company's commercially available SiCore ® and SiMaxx™ batteries deliver up to 450 Wh/kg and 1,150 Wh/L, with third-party validation of 500 Wh/kg and 1,300 Wh/L. The Company's corporate headquarters is in Fremont, California, where it maintains an R&D lab and a MWh scale manufacturing facility for the fabrication of silicon anodes and cells. To serve customer demand, Amprius entered into several agreements to secure over 1.8 GWh of contract manufacturing capacity. For additional information, please visit Also, see the Company's LinkedIn page. Safe Harbor Statement This release contains certain forward-looking statements based on our current expectations, forecasts and assumptions that involve risks and uncertainties. Forward-looking statements in this release are based on information available to us as of the date hereof. Our actual results may differ materially from those stated or implied in such forward-looking statements, due to risks and uncertainties associated with our business, which include the risk factors disclosed in our Form 10-K filed with the Securities and Exchange Commission on March 31, 2025, as may be amended or supplemented by other reports we file with the Securities and Exchange Commission from time to time. Forward-looking statements include statements regarding our expectations, beliefs, intentions, or strategies regarding the future and can be identified by forward-looking words such as 'anticipate,' 'believe,' 'could,' 'estimate,' 'expect,' 'intend,' 'may,' 'should,' and 'would' or similar words. All forecasts are provided by management in this release are based on information available at this time and management expects that internal projections and expectations may change over time. In addition, the forecasts are entirely based on management's best estimate of our future financial performance given our current contracts, current backlog of opportunities and conversations with new and existing customers about our products and services. We assume no obligation to update the information included in this press release, whether as a result of new information, future events or otherwise.
